[go: up one dir, main page]

MX2017000231A - Ajuste del ph para mejorar la recuperacion por descongelamiento de bancos de celulas. - Google Patents

Ajuste del ph para mejorar la recuperacion por descongelamiento de bancos de celulas.

Info

Publication number
MX2017000231A
MX2017000231A MX2017000231A MX2017000231A MX2017000231A MX 2017000231 A MX2017000231 A MX 2017000231A MX 2017000231 A MX2017000231 A MX 2017000231A MX 2017000231 A MX2017000231 A MX 2017000231A MX 2017000231 A MX2017000231 A MX 2017000231A
Authority
MX
Mexico
Prior art keywords
adjustment
cell banks
thaw recovery
improve
improve thaw
Prior art date
Application number
MX2017000231A
Other languages
English (en)
Inventor
J Meier Steven
Calhoun Kara
MEIER Angela
DUFFY Phillip
COYNE Marcia
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2017000231A publication Critical patent/MX2017000231A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fuel Cell (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

En la presente se proporcionan métodos para congelar células de mamíferos para su almacenamiento o mejorar la recuperación por descongelamiento de los bancos de células que comprenden congelar células de mamíferos en un medio de congelamiento que presenta un pH de 6.7 a 8.5.
MX2017000231A 2014-07-09 2015-07-09 Ajuste del ph para mejorar la recuperacion por descongelamiento de bancos de celulas. MX2017000231A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462022392P 2014-07-09 2014-07-09
PCT/US2015/039757 WO2016007752A1 (en) 2014-07-09 2015-07-09 Ph adjustment to improve thaw recovery of cell banks

Publications (1)

Publication Number Publication Date
MX2017000231A true MX2017000231A (es) 2017-06-27

Family

ID=53872132

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000231A MX2017000231A (es) 2014-07-09 2015-07-09 Ajuste del ph para mejorar la recuperacion por descongelamiento de bancos de celulas.

Country Status (18)

Country Link
US (3) US10602739B2 (es)
EP (2) EP3777535A1 (es)
JP (3) JP6826975B2 (es)
KR (1) KR102355306B1 (es)
CN (1) CN106686977B (es)
AU (1) AU2015287760B2 (es)
BR (1) BR112017000142B1 (es)
CA (1) CA2953154C (es)
ES (1) ES2825574T3 (es)
HR (1) HRP20201663T1 (es)
IL (1) IL249659B (es)
MX (1) MX2017000231A (es)
PL (1) PL3166401T3 (es)
RU (1) RU2714759C2 (es)
SG (1) SG11201700097WA (es)
SI (1) SI3166401T1 (es)
WO (1) WO2016007752A1 (es)
ZA (1) ZA201700178B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016007752A1 (en) 2014-07-09 2016-01-14 Genentech, Inc. Ph adjustment to improve thaw recovery of cell banks
CN106954623A (zh) * 2016-01-11 2017-07-18 华北制药集团新药研究开发有限责任公司 一种哺乳动物悬浮细胞的冻存溶液及冻存方法
CN106119186B (zh) * 2016-06-24 2019-10-08 肇庆大华农生物药品有限公司 一种用于全悬浮培养mdck细胞的无血清培养基及其制备方法
KR102236427B1 (ko) * 2019-06-05 2021-04-06 연세대학교 산학협력단 오가노이드의 동결 보존용 조성물
EP3795672B1 (en) * 2019-09-18 2024-11-20 Sartorius Stedim Biotech GmbH System and method for the generation of high cell density seed culture
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4515893A (en) 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US5672347A (en) 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5720937A (en) 1988-01-12 1998-02-24 Genentech, Inc. In vivo tumor detection assay
DE68919361T2 (de) 1988-06-21 1995-05-24 Genentech Inc Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
WO1990003430A1 (en) 1988-09-23 1990-04-05 Cetus Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
ATE139258T1 (de) 1990-01-12 1996-06-15 Cell Genesys Inc Erzeugung xenogener antikörper
WO1996033735A1 (en) 1995-04-27 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
DK0814159T3 (da) 1990-08-29 2005-10-24 Genpharm Int Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
EP0602126B1 (en) 1991-08-14 2003-03-05 Genentech, Inc. Immunoglobulin variants for specific fc epsilon receptors
AU672775B2 (en) * 1992-01-21 1996-10-17 Cobe Laboratories Inc. Method of freezing cells and cell-like materials
JPH0646840A (ja) * 1992-08-04 1994-02-22 Nippon Zenyaku Kogyo Kk 細胞凍結保存液
DE69315847T2 (de) 1992-08-21 1998-06-25 Genentech Inc Verfahren zur behandlung einer durch lfa-1 vermittelten störung
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
DK0733207T3 (da) 1993-12-10 1998-04-20 Genentech Inc Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika
EP0739214B1 (en) 1994-01-18 1998-03-18 Genentech, Inc. A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
US5686070A (en) 1994-03-03 1997-11-11 Genentech, Inc. Methods for treating bacterial pneumonia
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
JPH11507535A (ja) 1995-06-07 1999-07-06 イムクローン システムズ インコーポレイテッド 腫瘍の成長を抑制する抗体および抗体フラグメント類
WO1997026912A2 (en) 1996-01-23 1997-07-31 Genentech, Inc. Anti-cd18 antibodies for use against stroke
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
ATE267257T1 (de) 1996-11-27 2004-06-15 Genentech Inc Humanisierte anti-koerper gegen cd11a
JP4215172B2 (ja) 1996-12-03 2009-01-28 アムジェン フレモント インク． 複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
JP3957765B2 (ja) 1997-04-07 2007-08-15 ジェネンテク・インコーポレイテッド 抗ｖｅｇｆ抗体
EP1860187B1 (en) 1997-05-15 2011-07-13 Genentech, Inc. Apo-2 receptor
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
US6485959B1 (en) * 1998-10-07 2002-11-26 Cedars Sinai Medical Center Cell preconditioning and cryopresevation medium
US20030049840A1 (en) * 1998-10-07 2003-03-13 Demetriou Achilles A. Cell preconditioning and cryopreservation medium
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
JP2003510087A (ja) 1999-09-27 2003-03-18 ジェネンテック・インコーポレーテッド アポトーシス阻害剤を用いた組換えタンパク質の作成方法
BR0015224A (pt) 1999-10-29 2002-07-09 Genentech Inc Anticorpo anti-antìgeno de célula estaminal prostática (psca) isolado, anticorpo monoclonal anti-psca, ácido nucleico isolado, vetor de expressão, célula, célula hospedeira, método de produção de anticorpo, composição método in vitro para matar uma célula cancerosa que expresse psca, uso de uma anticorpo monoclonal anti-psca e artigo industrializado
US7208265B1 (en) 1999-11-24 2007-04-24 Xy, Inc. Method of cryopreserving selected sperm cells
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
WO2005094576A2 (en) * 2004-03-25 2005-10-13 Community Hospitals Of Indiana, Inc. Cryopreservation media
US9055739B2 (en) 2004-09-24 2015-06-16 Seiren Kabushiki Kaisha Compositions for cryopreservation of cells
JP4588598B2 (ja) * 2004-09-24 2010-12-01 セーレン株式会社 細胞凍結保存用組成物
KR101235658B1 (ko) * 2004-11-10 2013-02-21 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 Ｃｈｏ 세포에 대한 세포 뱅킹 전략을 최적화하기 위한 유동 세포측정 분석의 용도
KR101368924B1 (ko) 2005-11-17 2014-03-04 니뽄젠야쿠코교 가부시키가이샤 세포 보존용 수용액
CA2635978A1 (en) * 2006-01-04 2007-07-12 Do-Coop Technologies Ltd. Solid-fluid composition
JP4977389B2 (ja) * 2006-03-22 2012-07-18 シスメックス株式会社 細胞保存液及び細胞保存方法
EP2155777A2 (en) * 2007-04-10 2010-02-24 The Administrators of the Tulane Educational Fund Soluble and membrane-anchored forms of lassa virus subunit proteins
WO2011047380A2 (en) * 2009-10-16 2011-04-21 Mehmet Toner Methods for the cryopreservation of mammalian cells
WO2011089391A1 (en) * 2010-01-21 2011-07-28 Cambridge Enterprise Limited Mammalian cell preservation methods
CL2010000920A1 (es) * 2010-08-30 2010-12-17 Metodo para criopreservar espermatozoides humanos libres de plasma seminal, mediante un proceso rapido y simple de vitrificacion - desvitrificacion aseptica; un kit portable para el montaje del metodo.
RU2508397C1 (ru) * 2012-10-04 2014-02-27 Федеральное Государственное Бюджетное Учреждение Науки Институт Биохимической Физики Им. Н.М. Эмануэля Российской Академии Наук (Ибхф Ран) Способ криоконсервации клеток фототрофных микроорганизмов
EP2721930A1 (en) * 2012-10-19 2014-04-23 Serumwerk Bernburg AG Solution for cryopreservation, method of manufacturing the same, and its use
EP2967836B1 (en) * 2013-03-13 2018-10-10 Stratatech Corporation Cryopreservation of viable human skin substitutes
WO2015150394A1 (en) * 2014-04-01 2015-10-08 Pharmacosmos A/S Cryoprotective agent, cryoprotective and cryopreserved compositions, uses thereof, and methods of cryopreservation
US9813410B2 (en) 2014-06-26 2017-11-07 Rakuten, Inc. Information processing apparatus, information processing method, and information processing program
WO2016007752A1 (en) 2014-07-09 2016-01-14 Genentech, Inc. Ph adjustment to improve thaw recovery of cell banks

Also Published As

Publication number Publication date
IL249659A0 (en) 2017-02-28
US10602739B2 (en) 2020-03-31
ES2825574T3 (es) 2021-05-17
US12016328B2 (en) 2024-06-25
JP2017521075A (ja) 2017-08-03
JP2023075125A (ja) 2023-05-30
IL249659B (en) 2019-09-26
PL3166401T3 (pl) 2021-01-25
SI3166401T1 (sl) 2020-11-30
US20170112122A1 (en) 2017-04-27
RU2017104107A (ru) 2018-08-09
US20200315162A1 (en) 2020-10-08
BR112017000142B1 (pt) 2021-08-17
JP2020072668A (ja) 2020-05-14
CA2953154A1 (en) 2016-01-14
KR20170027831A (ko) 2017-03-10
AU2015287760A1 (en) 2017-02-02
RU2714759C2 (ru) 2020-02-19
US20220151221A1 (en) 2022-05-19
CA2953154C (en) 2023-03-14
CN106686977A (zh) 2017-05-17
NZ727705A (en) 2023-12-22
EP3166401B1 (en) 2020-08-19
RU2017104107A3 (es) 2019-02-15
WO2016007752A1 (en) 2016-01-14
BR112017000142A2 (pt) 2017-11-07
EP3166401A1 (en) 2017-05-17
EP3777535A1 (en) 2021-02-17
AU2015287760B2 (en) 2019-06-20
JP6826975B2 (ja) 2021-02-10
ZA201700178B (en) 2020-05-27
KR102355306B1 (ko) 2022-01-24
NZ765734A (en) 2024-01-26
SG11201700097WA (en) 2017-02-27
HRP20201663T1 (hr) 2020-12-25
CN106686977B (zh) 2022-03-25

Similar Documents

Publication Publication Date Title
MX2017000231A (es) Ajuste del ph para mejorar la recuperacion por descongelamiento de bancos de celulas.
CL2015003599A1 (es) Solucion que contiene theralosa y dextrano para transplantar celulas de mamiferos
AR100889A1 (es) Estimación del rendimiento de producción de un pozo en sistemas de yacimientos fracturados
CL2015003393A1 (es) Método y sistema para extraer rápidamente carbonato de litio de agua de lago salino.
EP3560334A4 (en) CELL FREEZING MEDIUM FOR CLINICAL USE
MX391259B (es) Composiciones y métodos para reducir la formación de cristales de hielo.
MX374915B (es) Uso de excipientes polimericos para liofilizacion o congelacion de particulas.
CR20150546A (es) Método para aumentar el rendimiento en semilla
ES2722207T3 (es) Procedimientos para la crioconservación de células epiteliales de pigmento retiniano derivadas de citoblastos crecidas sobre un sustrato polimérico
MX2016004575A (es) Metodos de modificacion de celulas huespedes.
GT201300276A (es) Uso del anticuerpo anti-cd19 inmunoconjugado con maitansinoide para el tratamiento del síntoma tumores de células b
AR082586A1 (es) Productos dulces no perecederos
CL2013002068A1 (es) Linea celular de ratón con genes inactivados nav1.7 global viable; metodo para generar ratón con dichos genes inactivados; hibridoma.
MX2016000349A (es) Sistema fotovoltaico-termico de recoleccion de energia solar con almacenamiento de energia.
PT2691110E (pt) Meios e métodos para imunoterapêutica celular ativa de cancro utilizando células tumorais mortas por pressão hidrostática elevada e células dendríticas
BR112015021189A2 (pt) métodos de banco de células de alta densidade
DK2956183T3 (da) Faste substrater til fremme af celle og væv vækst
BR112017020690A2 (pt) produção livre de células de ácido ribonucleico
CL2014001964A1 (es) Composicion herbicida sólidas que comprende un herbicida de la clase de inhibidores de la enzima accasa y als y de los compuestos derivados de pirimidina o piridina mejoradas con adyuvante incorporado; metodo para controlar vegetación indeseable en un ambiente acuático.
LT3250202T (lt) Kompozicija, skirta naudoti kraujodaros kamieninių ląstelių po transplantacijos prigijimo pagerinimui
PE20161197A1 (es) Sistemas y metodos para reparar membranas y mejorar el rendimiento de los sistemas de membranas impulsados osmoticamente
CL2016000516A1 (es) Método y sistema de preparación de carbonato de litio de alta pureza.
CO6910192A2 (es) Composiciones y métodos para tratar el cáncer usando el inhibidor de pi3kbeta y el inhibidor de la vía de map, incluídos los inhibidores de mek y raf
ES2722405T3 (es) Procedimiento de coagulación por congelación continuo o semicontinuo para dispersiones poliméricas acuosas
BR112014007624A2 (pt) método para operar um sistema de refrigeração, e, geladeira